Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry

Iron overload due to red blood cell (RBC) transfusions is associated with morbidity and mortality in lower-risk myelodysplastic syndrome (MDS) patients. Many studies have suggested improved survival after iron chelation therapy (ICT), but valid data are limited. The aim of this study was to assess t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Hoeks, Marlijn, Yu, Ge, Langemeijer, Saskia, Crouch, Simon, de Swart, Louise, Fenaux, Pierre, Symeonidis, Argiris, Čermák, Jaroslav, Hellström-Lindberg, Eva, Sanz, Guillermo, Stauder, Reinhard, Holm, Mette Skov, Mittelman, Moshe, Mądry, Krzysztof, Malcovati, Luca, Tatic, Aurelia, Almeida, Antonio Medina, Germing, Ulrich, Savic, Aleksandar, Šimec, Njetočka Gredelj, Culligan, Dominic, Itzykson, Raphael, Guerci-Bresler, Agnes, Slama, Borhane, Droste, Jackie, van Marrewijk, Corine, van de Loosdrecht, Arjan, Blijlevens, Nicole, van Kraaij, Marian, Bowen, David, de Witte, Theo, Smith, Alex
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7049356/
https://ncbi.nlm.nih.gov/pubmed/31278207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.212332
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados